EUVIMEDEUVIMED entdecken
Crossref

Valsartan and Amlodipine Improved Haematological and Biochemical Indices of Vildagliptin-treated Streptozotocin-induced Diabetic Rats

Israel Olapeju Bolanl, Osayemwenre Erharuyi, Abigail M. Akhigbemen, Amenaghawon Imuetinyan Ugiagbe, Edobor Ekugum, Samuel O. Nwusulor, Keziah E. Adudu, Abiodun Falodun

Pharmaceutical and Biomedical Research · 01.03.2025 · 11 (2) · 95-104

DOI: 10.32598/pbr.11.2.671.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical and Biomedical Research, erschienen am 01.03.2025. Verfasst von Israel Olapeju Bolanl und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valsartan and Amlodipine Improved Haematological and Biochemical Indices of Vildagliptin-treated Streptozotocin-induced Diabetic RatsBackground: Diabetes mellitus (DM) and hypertension often coexist in sufferers, which exacerbates the complications of DM.Also, the impacts of antihypertensive medications on the treatment outcomes of DM are not fully understood.

Objectives

Our objective was to evaluate the effect of valsartan and amlodipine on the hematological and biochemical differentials of vildagliptin-treated streptozotocin-induced diabetic rats.

Methods

DM was induced in male Wistar rats by a single intraperitoneal dose of streptozotocin (40 mg/kg body weight).The animals were grouped as non-diabetic rats (control), untreated diabetic rats, and diabetic rats treated with 5 mg/kg vildagliptin only, 5 mg/kg plus 30 mg/ kg of vildagliptin and valsartan, respectively, and 5 mg/kg plus 2.5 mg/kg of vildagliptin and amlodipine, respectively.Drugs were administered orally, and rats were treated daily for three weeks.Then, blood samples were collected for hematological and biochemical analyses.

Results

The addition of amlodipine and valsartan as adjuncts to vildagliptin appeared to alter the evaluated differentials compared to vildagliptin treatment alone.Furthermore, the assessment of renal and liver functions, as well as the lipid profile, showed that treatment with valsartan as an adjunct improved the outcomes.

Conclusion

Our findings therefore suggest that amlodipine and valsartan brought about significant alterations in the differentials of diabetic rats treated with vildagliptin.

Zitieren

APA

Bolanl, I. O., Erharuyi, O., Akhigbemen, A. M., Ugiagbe, A. I., Ekugum, E., Nwusulor, S. O., Adudu, K. E., & Falodun, A. (2025). Valsartan and Amlodipine Improved Haematological and Biochemical Indices of Vildagliptin-treated Streptozotocin-induced Diabetic Rats. Pharmaceutical and Biomedical Research, 11(2), 95-104. https://doi.org/10.32598/pbr.11.2.671.3

Vancouver

Bolanl IO, Erharuyi O, Akhigbemen AM, Ugiagbe AI, Ekugum E, Nwusulor SO, et al. Valsartan and Amlodipine Improved Haematological and Biochemical Indices of Vildagliptin-treated Streptozotocin-induced Diabetic Rats. Pharmaceutical and Biomedical Research. 2025;11(2):95-104. doi:10.32598/pbr.11.2.671.3

BibTeX
@article{Bolanl2025,
  author = {Bolanl, Israel Olapeju and Erharuyi, Osayemwenre and Akhigbemen, Abigail M. and Ugiagbe, Amenaghawon Imuetinyan and Ekugum, Edobor and Nwusulor, Samuel O. and Adudu, Keziah E. and Falodun, Abiodun},
  title = {Valsartan and Amlodipine Improved Haematological and Biochemical Indices of Vildagliptin-treated Streptozotocin-induced Diabetic Rats},
  journal = {Pharmaceutical and Biomedical Research},
  year = {2025},
  volume = {11},
  number = {2},
  pages = {95--104},
  doi = {10.32598/pbr.11.2.671.3}
}
Kostenlos starten →